Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

First-in-human data from SAD and MAD studies of LTI-291 in healthy volunteers

Feb. 22, 2021

Dopamine progenitor cell product MSK-DA01 ameliorates Parkinsonian deficits in animal model

Feb. 19, 2021

Bionomics enters MoU with EmpathBio to explore combination of BNC-210 and EMP-01 for PTSD

Feb. 19, 2021

SciSparc signs agreement for phase IIa trial of SCI-110 for Alzheimer agitation

Feb. 18, 2021

AbFero receives funding for development of SP-420 for Parkinson's disease

Feb. 18, 2021

First patient dosed in phase I study of IkT-148009

Feb. 18, 2021

Sichuan Haisco Pharmaceutical identifies kappa-opioid receptor agonist derivatives

Feb. 18, 2021

Topline data from phase Ib study of AMG-0103 in chronic discogenic low back pain

Feb. 18, 2021

Small molecule targeting ER stress-responsive chaperones suppresses abnormal tau protein aggregation

Feb. 17, 2021

Mice can inherit paternal depression via sperm microRNA

Feb. 17, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 20, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
WHO declares Ebola outbreak a public health emergency of international concern
BioWorld
The threat posed by the Ebola outbreak in the Democratic Republic of Congo has intensified, with the confirmation that it is caused by the Bundibugyo species of...
Nxera Pharma prepares and tests new GPR17 antagonists
BioWorld Science
Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...
‘Detargeted’ targeted gene therapy improves activity in Pompe
BioWorld
A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...